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Hand, food and mouth disease (HFMD) is a com-
mon infection characterized by fever, stomatitis and 
a  vesicular rash affecting the hands, feet, and occa-
sionally the buttocks. The disease is usually mild and 
self-limiting, but serve neurological and systemic syn-
dromes that can be fatal occur in some patients. HFMD 
is common in children younger than 5  years old, 
but can also occur in older children and adults. It is 
caused by human enteroviruses (HEVs) belonging to the 
Picornaviridae family. The most common etiologic 
agents are coxsackievirus A16 (CVA16) and enterovirus 
71 (EV71), but other enteroviruses, mainly belonging to 
the species HEV-A (CVA2, CVA4-8, CVA10, CVA12), 
but also HEV-B (echoviruses: E4, E7, E9, E11, E25, E30 
and CVB1-5, CVA9, EV84) have been associated with 
illness (Lei et al., 2015).
Recently, the switch of HFMD etiology has been 
suggested by the increased epidemics of serotypes other 
than EV71 and CVA16, including CVA6, CVA10, and 
CVA12. Serve HFMD in children and atypical HFMD 
in adults has been reported in association with CVA6 
(Lott et al., 2013). The switch of HFMD etiology 
requires a precise virus genotyping in the surveillance 
for a better HFMD control. 
There are no published data available on the inci-
dence of HFMD in Poland, there is no active public 
health surveillance for HFMD and it is not a notifi-
able infection. Whereas EV71 has been occasionally 
detected in clinical samples (Wieczorek and Krzyszto-
szek, 2016). To better understand the molecular char-
acteristics of enteroviruses circulating in Poland, par-
ticularly the diversity of those viruses associated with 
HFMD, we examined clinical material from HFMD 
cases, that occurred during the period 2013–2016, in 
three regions of Poland. 
Since November 2013 to March 2016, a total of 
28 specimens (10 stools, 18 throat swabs) were collected 
from 27 clinically diagnosed HFMD cases (Fig. 1) from 
3 voivodoships. Patient’s age ranged from 5 months to 
17 years (Table I). The clinical samples were tested with 
diagnostic pan-enterovirus RT-PCR. Viral RNA was 
extracted from 140 μl of the sample using QIAamp Viral 
RNA Mini Kit (Qiagen) following the manufacturer’s 
instructions. RT-PCR was carried out using pan-entero-
virus primers based on the WHO manual (WHO, 2004). 
This set of primers produces a product of 114 bp and has 
been designed to detect and amplify a genome segment 
present at the 5’NCR of the enterovirus genomes. Out of 
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28 samples, 20 (71.4%) were positive for enteroviruses 
using RT-PCR, 10 stools (100%) and 10 swabs (55.5%). 
Viruses have been isolated from throat swabs and 
stool specimens by conventional cell culture method 
using WHO recommendations. Isolation was per-
formed on RD cells (human rhabdomyosarcoma). 
A volume of 200 μl of the sample was inoculated into 
tubes with RD cells. The tubes were incubated at 36°C 
and were examined daily. After 7 days, the tubes were 
frozen and thawed and re-passaged, and anther 7-day 
examination was performed. Each specimen underwent 
three passages. The study found that among the sam-
ples with positive RT-PCR results 6 (30%) were positive. 
Enterovirus was isolated from the stools of 6 patients 
and not even one throat swab. Complete cytopathic 
effect (CPE) has occurred after 12 to 23  days post-
inoculation (Table I).
To identify the enterovirus type in positive samples, 
RT-PCR specific for a partial sequence of the viral pro-
 1 672/PL30/2013 f/1 y wielkopolskie XI.2013 stool + (23d) + + CVA10
 2 1HFMD/PL14/2014 f/9 m mazowieckie VII.2014 throat swab – + –
 3 2HFMD/PL14/2014 m/9 y mazowieckie VII.2014 throat swab – – –
 4 3HFMD/PL14/2014 f/2 y mazowieckie VII.2014 throat swab – + –
 5 4HFMD/PL14/2014 f/17 y mazowieckie VII.2014 throat swab – – –
 6 0610/PL14/2014 m/2 y mazowieckie X.2014 stool + (17d) + + CVA6
 7 5HFMD/PL14/2014 f/1 y mazowieckie X.2014 stool + (14d) + + CVA6
 8 6HFMD/PL14/2014 m/3 y mazowieckie X.2014 stool + (15d) + + CVA16
 9 7HFMD/PL14/2014 m/9m mazowieckie X.2014 stool – + + CVA6
10 8HEMD/PL14/2015 f/5 y mazowieckie III.2015 stool + (13d) + + CVA16
11 9HFMD/PL14/2015 f/2 y mazowieckie III.2015 stool + (12d) + + CVA16
12 20HFMD/PL02/15 m/11 y dolnośląskie IV.2015 throat swab – – –
13 10HFMD/PL14/2015 m/4 y mazowieckie VI.2015 stool – + + CVA6
14 11HFMD/PL14/2015 m/2 y mazowieckie VI.215 stool – + + CVA6
15 19HFMD/PL02/2015 f/15 y dolnośląskie VI.2015 throat swab – + –
16 18HFMD/PL02/2015 m/7 y dolnośląskie VII.2015 throat swab – + –
17 16HFMD/PL02/2015 f/5 m dolnośląskie VIII.2015 throat swab – – –
18 17HFMD/PL02/2015 m/11 y dolnośląskie VIII.2015 throat swab – + –
19 24HFMD/PL02/2015 m/1 y dolnośląskie XI.2015 stool – + –
20 24HFMD/PL02/2015 m/1 y dolnośląskie XI.2015 throat swab – – –
21 28HFMD/PL02/2015 m/1 y dolnośląskie XI.2015 throat swab – + + CVA6
22 13HFMD/PL02/2015 m/1 y dolnośląskie XI.2015 throat swab – + + CVA6
23 14HFMD/PL02/2015 m/2 y dolnośląskie XI.2015 throat swab – + + CVA6
24 15HFMD/PL02/2015 m/1 y dolnośląskie XI.2015 throat swab – + –
25 12HFMD/PL02/2015 m/1 y dolnośląskie XII.2015 throat swab – – –
26 21HFMD/PL02/2016 m/7 m dolnośląskie II.2016 throat swab – + + CVA6
27 22HFMD/PL02/2016 m/13 y dolnośląskie II.2016 throat swab – – –
28 23HFMD/PL02/2016 f/16 y dolnośląskie III.2016 throat swab – – –
Table I
Laboratory findings in clinical specimens and epidemiologic data for patients with HFMD, Poland 2013–2016.











Fig. 1. Child with atypical hand, food and, month disease
associated with coxsackievirus A6 infection, Wroclaw, Poland,
February 2016.
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tein  1 (VP1) region, was performed by using Super-
script III (Invitrogen) followed by a second amplifica-
tion reaction with nested primers for species A and B 
VP1 sequences and PCR cycling times and temperature 
as previously described (Leitch et al., 2009). Amplified 
products were analysed in 1.5% agarose gels, GelRed-
stained, and examined under a UV DNA transillumi-
nator. The resulting DNA templates were processed in 
cycle sequencing reaction with a BigDye 3.1 according 
to manufacturer’s protocol. The pro duct of sequenc-
ing reaction was run in an automated genetic ana-
lyser (Applied Biosystems, model 3730). The resulting 
sequences were manually edited using BioEdit program 
and examined in terms of closest homologue sequence 
using BLAST software (http://www.ncbi.nlm.nih.gov/
BLAST/). The sequences of isolated strains (region 
VP1) were aligned with the reference strains. A phylo-
genetic tree was computed using the neighbor-joining 
method with bootstrap 1000 replicates. Molecular and 
phylogenetic analyses were conducted using MEGA 
version 6.06 (Tamura et al., 2013) (http://www.megas-
oftware.net/). Sequences have been assigned GenBank 
accession numbers KX865266 to KX865274. 
Out of 20 positive samples, 13 were positive in reac-
tion characteristic for species A and none in reaction 
for species B. A total of 3 different serotypes of species 
A were identified by partial VP1 sequencing (CVA10, 
CVA6, CVA16). The typed strains included 6 cell culture 
Fig. 2. Phylogenetic tree depicting the relationships between partial capsid gene sequences of 9 Polish CVA6 strains
isolated from 2013 to 2016 and 23 sequences from GenBank (609 nt). Each strain is referenced by its geographical
origin and its accession number.
The tree was constructed by neighbour-joining method and evaluated with 1000 bootstrap pseudoreplicates.
Only bootstrap values ≥ 80% are indicated. In the analyses, genetic distances were calculated
with Kimura 2-parameter algorithm. Analyses were conducted in MEGA 6.06 (Tamura et al., 2013).
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isolates and 7 strains primarily detected by RT-PCR. 
CVA6 was identified in 9 and CVA16 in 3 typed cases, 
respectively. One patient was positive for CVA10.
Genetic analysis of viral sequences showed that 
CVA6 strains were divided into two clusters (Fig. 1). 
In general, nucleotide sequence divergence in pair-
wise comparisons among isolates range from 0.0% to 
7.5% (0.0–2.5% amino acid divergence). Compared 
with the prototype strain Gdula, the genetic diver-
gence increased to 18.4–20.0%. Cluster I includes three 
sequences of CVA6 isolated in 2014–2015, presenting 
1.0–5.6% nucleotide divergence (0.5–2.0% amino acid 
divergence). These strains had closest genetic relation-
ship with isolates previously identified in various geo-
graphical origins (China 2010–2013, United Kingdom 
2013, Japan 2013). Cluster II, comprised six strains 
from 2014–2016, presenting 0.0–5.6% VP1 nucleotide 
sequence divergence (0.0–2.0% amino acid divergence). 
Virus strains belonged to cluster II grouped together 
with strains isolated in the United Kingdom (2014) 
and China (2009–2014) (Fig. 2). Three Polish CVA16 
strains from 2014–2015, were genetically homoge-
neous, presenting 0.0–2.0% nucleotide divergence and 
were closely related to Chinese strains isolated in 2011. 
One strain CVA10 grouped together with those from 
Russia isolated in 2009–2013 and Spain (2008).
In Poland, there is no the surveillance of HFMD. 
Therefore, little is known about the pathogenic roles 
of enteroviruses, their geographic distributions, and 
epidemiological data. The results demonstrated that 
CVA6, CVA10, and CVA16 emerged and co-circulated 
in Poland. To the best of our knowledge, this is the 
first report of CVA6 infections associated with HFMD 
in Poland. As an emerging pathogen, CVA6 increas-
ingly became as common a causative agent of HFMD 
in Poland as was CVA16. CVA6 has been associated 
with more severe and extensive rash than HFMD 
caused by other enteroviruses (Wei et al., 2011). Since 
2008, international outbreaks of CVA6 HFMD in chil-
dren and adults have been described (Osterback et al., 
2009; Blomqvist et al., 2010; Wu et al., 2010; Wei et al., 
2011; Fujimoto et al., 2012; Mirand et al., 2012; Puenpa 
et al., 2013; Cabrerizo et al., 2013; Sinclair et al., 2014), 
but no outbreaks had been reported in Poland pre-
viously. Although all 9 of the CVA6 strains identified 
in the Polish cases were genetically closely related 
(based on partial VP1 gene sequences) to CVA6 strains 
identified in recent international outbreaks. Two gene-
tically distinct CVA6 clusters were co-circulating in 
Poland suggesting two independent introductions of 
the virus to Poland. It may be noted that the analysis 
of data obtained in this study was limited due to the 
small size of samples available.
In mild cases of HFMD laboratory testing is not 
necessary. Testing is usually reserved for severe cases 
and public health investigation of outbreaks. Of the 
20 samples identified as HEV on the basis of the 5’NCR, 
only 13 could be typed using primers specific to the VP1 
region. The failure of amplification of typing regions in 
seven specimens may have been due to a low viral load. 
Genotyping was performed directly in clinical speci-
mens for 7 samples and for 6 isolates. HEV identification 
was effective for 50% of the EV-positive clinical samples 
and for 100% of the isolates. During the 2008 Finnish 
outbreak, EV identification was effective for 55% of the 
EV-positive clinical samples (Blomqvist et al., 2010). In 
most epidemiological studies of HFMD, enterovirus 
genotyping relies on virus isolates despite the difficulty 
of growing HEV-A serotypes in cell culture. 
CVA are generally difficult to grow in culture 
(Nsaibia et al., 2007). Because of this feature, isolation 
from clinical material is often unsuccessful. Most CVA 
could propagate in RD cells, but they generally require 
more than one passage before inducing a detectable 
cytopathic effect. In this study, all the isolates were 
obtained on RD cell in the second or third passage 
and only from stool specimen. All identified CVA10 
and CVA16 strains were able to multiply in RD cells, 
whereas only 40% of identified CVA6 strains showed 
successful propagation in RD cells, suggesting that 
CVA6 is more difficult to isolate than CVA16 or CVA10.
As HFMD is not a notifiable disease in Poland, the 
actual number of HFMD cases is not known. Entero-
viral infections are underdiagnosed as a result of the 
lack of routine surveillance and also frequently atypical 
presenting symptoms and signs. In addition, increas- 
ing awareness will help to improve laboratory diagno-
sis and management of infected children. Improved 
HFMD surveillance is required, with virus genotyping 
as a key element.
In summary, the present investigation highlights 
the co-circulation of CVA6, CVA10 and CVA16 types 
causing HFMD in Poland. These results emphasize the 
need for continuous monitoring of HFMD in Poland 
and facilitation of the diagnosis of the associated HEV 
infections using molecular approaches. 
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